SCHEMBL4028623

SCHEMBL4028623

O=C(CC1(c2ccccc2)CCN(C(=O)c2ccc(F)cc2)CC1)NCCc1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.60
RAB9A P51151 3/20 0.50
ALDH1A1 P00352 2/20 0.50
NPC1 O15118 2/20 0.50
TLR2 O60603 2/20 0.48
TLR1 Q15399 2/20 0.48
MEN1 O00255 3/20 0.46
CYP3A4 P08684 1/20 0.45
CYP2C19 P33261 1/20 0.45
CACNA1G O43497 1/20 0.45
PKM P14618 1/20 0.44
TAAR1 Q96RJ0 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
KDM4E B2RXH2 1/20 0.44
TSHR P16473 1/20 0.43
HTR1A P08908 1/20 0.43
DRD3 P35462 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2473653 0.89 KMT2A (0.47) KMT2AALDH1A1NPC1TLR2TLR1
SCHEMBL2493317 0.84 RORC (0.46) KMT2ARAB9AALDH1A1MEN1CACNA1G
SCHEMBL2496581 0.79 MEN1 (0.47) KMT2ARAB9ANPC1MEN1CYP3A4
SCHEMBL2469517 0.79 TAAR1 (0.47) KMT2AALDH1A1MEN1TAAR1SMN1; SMN2
SCHEMBL2473161 0.78 NPC1 (0.49) RAB9AALDH1A1NPC1CYP3A4CYP2C19
SCHEMBL2467016 0.77 LTA4H (0.43) KMT2AALDH1A1MEN1CACNA1GTAAR1
SCHEMBL2472974 0.77 KMT2A (0.57) KMT2ARAB9AALDH1A1NPC1TLR2
SCHEMBL2472016 0.77 KMT2A (0.47) KMT2AALDH1A1NPC1MEN1CYP3A4
SCHEMBL2473558 0.77 MCHR1 (0.46) KMT2AALDH1A1MEN1TAAR1
SCHEMBL4038012 0.77 HTR2A (0.45) RAB9AALDH1A1NPC1PKMTAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1501467-A4 HETEROCYCLO INHIBITORS OF POTASSIUM CHANNEL FUNCTION BRISTOL MYERS SQUIBB CO (US) 2009-08-19 EP disclosed
EP-1501467-A2 HETEROCYCLO INHIBITORS OF POTASSIUM CHANNEL FUNCTION Bristol-Myers Squibb Company (US) 2005-02-02 EP disclosed
WO-2003088908-A2 HETEROCYCLO INHIBITORS OF POTASSIUM CHANNEL FUNCTION BRISTOL-MYERS SQUIBB COMPANY (US) 2003-10-30 WO disclosed